ITC Will Probe Hemophilia B Med Patent Infringement Claims
The U.S. International Trade Commission has agreed to take up an investigation into whether the importer of a drug used to treat hemophilia B is infringing patents for a similar drug...To view the full article, register now.
Already a subscriber? Click here to view full article